「nov」の検索結果
21件：11～15件目を表示
-
お知らせ | 千寿製薬株式会社
日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
http://www.senju.co.jp/chinese/news/ -
お知らせ | 千寿製薬株式会社
日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
https://www.senju.co.jp/chinese/news/ -
Milestones in Our History | About Senju | SENJU Pharmaceutical
t for manufacturing established in Kanzaki-gun, Hyogo June Shoji Yoshida became the President. 1978 November Company head office relocated in Hiranomachi, Higashi-ku, Osaka. 1980 February Ophthalmic S...
https://www.senju.co.jp/english/about/history.html -
お知らせ | 千寿製薬株式会社
5 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
https://www.senju.co.jp/english/news/ -
お知らせ | 千寿製薬株式会社
5 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
http://www.senju.co.jp/english/news/